19 janv. 2005 - British-Columbia Trial
Description:
20-year LR (13 vs 39%) and OS (47 vs 37%) favored adjuvant RTmedian 11 LN sampled
For patients with high-risk breast cancer treated with modified radical mastectomy, treatment with radiation therapy (schedule of 16 fractions) and adjuvant chemotherapy leads to better survival outcomes than chemotherapy alone, and it is well tolerated, with acceptable long-term toxicity.
Ajouté au bande de temps:
Date:
19 janv. 2005
Maintenaint
~ Il y a 20 ans